CLINICAL_TRIALS
trial_result
· 2021-07-09
Clinical Trial Update: Long-term Efficacy, Safety and Tolerability of ACZ885 in Patients With Rheumatoid Arthritis [Phase 2]
Summary
Phase 2 clinical trial update on long-term efficacy, safety, and tolerability of ACZ885 in patients with rheumatoid arthritis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2021-07-09